Holen Sie sich die Stockscreener-App
7.28
7.85%
-0.62
Handel nachbörslich:
7.96
0.68
+9.34%
Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
2.525
|
- | 2.141 | 1.975 | 2.452 |
| Operating Income/Loss |
70.80%
-4.602
|
-15.76 | -3.227 | -7.404 | -3.119 |
| Nonoperating Income/Loss |
146.17%
-0.205
|
0.444 | -1.986 | -0.084 | 1.224 |
| Income/Loss From Continuing Operations Before Tax |
68.61%
-4.807
|
-15.31 | -5.213 | -7.488 | -1.895 |
| Income Tax Expense/Benefit, Deferred |
100.00%
-
|
-0.859 | - | - | - |
| Income Tax Expense/Benefit |
100.00%
-
|
-0.859 | 0.085 | -1.088 | - |
| Net Income/Loss |
66.75%
-4.807
|
-14.46 | -5.298 | -6.40 | -1.895 |
| Basic Average Shares |
20.68%
143,317.47
|
118,757.01 | - | 65,326.24 | 62,943.90 |
| Diluted Average Shares |
20.68%
143,317.47
|
118,757.01 | - | 65,326.24 | 62,943.90 |
| Basic Earnings Per Share |
-
|
- | - | - | - |
| Diluted Earnings Per Share |
-
|
- | - | - | - |
6.10%
5.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):